Latest Triple-negative breast cancer Stories

2011-12-08 23:28:02

Results presented at 2011 CTRC-AACR-San Antonio Breast Cancer Symposium Initial results from an ongoing clinical trial, the first designed to examine the utility of whole-genome sequencing for triple negative breast cancer, were reported today during the CRTC-AACR San Antonio Breast Cancer Symposium. The results indicate activation of targets not previously associated with triple negative disease and could point toward new treatment strategies. Based on mutations uncovered by...

2011-12-08 13:05:24

Hispanic women are more likely to die from breast cancer than non-Hispanic white women, according to research presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011. "This difference may be associated with a tumor phenotype that is less responsive to chemotherapy," said Kathy B. Baumgartner, Ph.D., professor of epidemiology and associate dean for faculty affairs in the School of Public Health and Information Sciences at the University of Louisville in...

2011-12-01 19:03:26

Sequencing points to treatment protocols, results in patient benefit Triple negative breast tumors, which make up nearly 20 percent of breast cancers, do not respond to treatment with targeted therapies such as Herceptin® (trastuzumab). To investigate new options for these patients, the first clinical trial of whole-genome sequencing for women with triple negative breast cancer was initiated in March 2010, and the first results will be presented during the 2011 CTRC-AACR San Antonio...

2011-11-28 17:11:52

The risk of breast cancer is increased by genetic and lifestyle factors such as the inherited BRCA2 gene, age of having first child, or use of hormone replacement therapy (HRT). New research published in BioMed Central's open access journal BMC Cancer looked at the relationship between women with breast cancer and diagnosis of cancer in their parents. The results showed that the chances of women with lobular breast cancer having a father with cancer (especially prostate cancer) was almost...

2011-10-05 07:00:00

Music Legend gets behind Lazarex Cancer Foundation Danville,Ca. (PRWEB) October 05, 2011 While cancer is colorblind, new studies show that minorities may not be screened or take part in possible life-saving clinical trials as often as their Caucasian counterparts. Dana Dornsife, founder of the Lazarex Cancer Foundation, is hoping to change that as R&B legend Lenny Williams joins forces with Lazarex Cancer Foundation to bring awareness to these groups. âœThe goal...

2011-10-05 12:35:37

Finding new treatments for triple negative breast cancer, an aggressive form of breast cancer that is often resistant to standard treatments and preferentially affects African-American women, is critically important, said a researcher from the Lester and Sue Smith Breast Center at Baylor College of Medicine. Approximately 26 percent of African-America women with breast cancer are triple-negative, compared to 15 percent of Caucasian women. "Even though this is one of the least common...

Word of the Day
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.